Regulatory
Regulatory news for fund managers and LPs: SEC exam priorities, enforcement actions, Advisers Act rule changes, private fund adviser regulation, Investment Company Act exemptions, and cross-border compliance developments.
LVS Advisory SPV I Files SEC Document
D - LVS Advisory SPV I A Series of V360 Holdings LLC filed a document with the SEC on March 9, 2026, as per EDGAR records.
MV Funds LP Series AC-1120 Fund I Files SEC Exemption
AC-1120 Fund I, a series of MV Funds LP, filed a notice under Section 3(c)(1) of the Investment Company Act on March 9, 2026, as per SEC EDGAR records.
Three Haven Capital Files Under Investment Company Act Section 3(c)(1)
Three Haven Capital, LP submitted a SEC filing on March 9, 2026, related to Section 3(c)(1) exemption.
Alpha Tau Medical Secures Japanese Approval for Alpha DaRT Cancer Therapy
Alpha Tau Medical receives first international regulatory approval for its Alpha DaRT device in Japan for head and neck cancer treatment.
Jain Global Files for 3(c)(7) Exemption, Signaling Institutional Focus
Singapore-based investment manager Jain Global Institutional Holdings registers with SEC under Section 3(c)(7) for qualified purchaser-only fund.
Farallon Capital Files SEC 3(c)(7) Registration, Targets Qualified Purchasers
The San Francisco hedge fund giant's latest SEC filing signals fundraising activity targeting sophisticated institutional investors.
Tenaron Capital Files Form D/A for New Offshore Fund Structure
Investment firm Tenaron Capital has amended its regulatory filing for a new offshore relative value fund targeting sophisticated investors.
